Suppr超能文献

CRISPR 筛选揭示了肠出血性大肠杆菌的 T3SS 和志贺毒素依赖于共享的宿主因子进行感染。

CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.

机构信息

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

mBio. 2018 Jun 19;9(3):e01003-18. doi: 10.1128/mBio.01003-18.

Abstract

Enterohemorrhagic (EHEC) has two critical virulence factors-a type III secretion system (T3SS) and Shiga toxins (Stxs)-that are required for the pathogen to colonize the intestine and cause diarrheal disease. Here, we carried out a genome-wide CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats with Cas9) loss-of-function screen to identify host loci that facilitate EHEC infection of intestinal epithelial cells. Many of the guide RNAs identified targeted loci known to be associated with sphingolipid biosynthesis, particularly for production of globotriaosylceramide (Gb3), the Stx receptor. Two loci (TM9SF2 and LAPTM4A) with largely unknown functions were also targeted. Mutations in these loci not only rescued cells from Stx-mediated cell death, but also prevented cytotoxicity associated with the EHEC T3SS. These mutations interfered with early events associated with T3SS and Stx pathogenicity, markedly reducing entry of T3SS effectors into host cells and binding of Stx. The convergence of Stx and T3SS onto overlapping host targets provides guidance for design of new host-directed therapeutic agents to counter EHEC infection. Enterohemorrhagic (EHEC) has two critical virulence factors-a type III secretion system (T3SS) and Shiga toxins (Stxs)-that are required for colonizing the intestine and causing diarrheal disease. We screened a genome-wide collection of CRISPR mutants derived from intestinal epithelial cells and identified mutants with enhanced survival following EHEC infection. Many had mutations that disrupted synthesis of a subset of lipids (sphingolipids) that includes the Stx receptor globotriaosylceramide (Gb3) and hence protect against Stx intoxication. Unexpectedly, we found that sphingolipids also mediate early events associated with T3SS pathogenicity. Since antibiotics are contraindicated for the treatment of EHEC, therapeutics targeting sphingolipid biosynthesis are a promising alternative, as they could provide protection against both of the pathogen's key virulence factors.

摘要

产肠毒素型大肠杆菌(EHEC)有两个关键的毒力因子——III 型分泌系统(T3SS)和志贺毒素(Stxs)——这对于病原体在肠道中定植并引起腹泻疾病是必需的。在这里,我们进行了全基因组 CRISPR/Cas9(成簇的规则间隔的短回文重复序列与 Cas9)功能丧失筛选,以鉴定促进 EHEC 感染肠上皮细胞的宿主基因座。许多鉴定的向导 RNA 靶向已知与鞘脂生物合成相关的基因座,特别是用于产生 Stx 受体神经节苷脂 Gb3。两个具有很大未知功能的基因座(TM9SF2 和 LAPTM4A)也被靶向。这些基因座的突变不仅挽救了 Stx 介导的细胞死亡的细胞,而且还防止了与 EHEC T3SS 相关的细胞毒性。这些突变干扰了与 T3SS 和 Stx 致病性相关的早期事件,显著减少了 T3SS 效应子进入宿主细胞和 Stx 结合。Stx 和 T3SS 对重叠宿主靶标的收敛为设计新的宿主定向治疗剂以对抗 EHEC 感染提供了指导。产肠毒素型大肠杆菌(EHEC)有两个关键的毒力因子——III 型分泌系统(T3SS)和志贺毒素(Stxs)——这对于在肠道中定植并引起腹泻疾病是必需的。我们筛选了来自肠上皮细胞的全基因组 CRISPR 突变体集合,并鉴定出在 EHEC 感染后具有增强生存能力的突变体。许多突变破坏了一组脂质(鞘脂)的合成,其中包括 Stx 受体神经节苷脂 Gb3,从而防止 Stx 中毒。出乎意料的是,我们发现鞘脂也介导与 T3SS 致病性相关的早期事件。由于抗生素不适合治疗 EHEC,针对鞘脂生物合成的治疗方法是一种很有前途的替代方法,因为它们可以提供对病原体这两个关键毒力因子的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd07/6016243/2c20464ba1b3/mbo0031839190001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验